Effect of Evacetrapib on the Pharmacokinetics and Pharmacodynamics of Warfarin in Healthy Subjects
Phase of Trial: Phase I
Latest Information Update: 15 Oct 2018
At a glance
- Drugs Evacetrapib (Primary) ; Warfarin
- Indications Atherosclerosis; Cardiovascular disorders; Hypercholesterolaemia; Hyperlipidaemia
- Focus Pharmacokinetics
- Sponsors Eli Lilly
- 27 Jun 2013 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 18 Jun 2013 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.
- 16 Apr 2013 New trial record